Skip to main content
. 2013 May 10;13:234. doi: 10.1186/1471-2407-13-234

Table 3.

Associations between candidate genes and glioma risk

Genotype Cases, n(%) Controls, n(%) OR (95% CI)a Ptrendb Pvalue for HWE test
XRCC3: rs861539 (T241M)
CC
336 (87.5)
340 (88.5)
1.00
0.835
0.165
CT
47 (12.2)
41 (10.7)
1.15 (0.73-1.79)
 
 
TT
1 (0.3)
3 (0.8)
0.33 (0.03-3.22)
 
 
XRCC3: rs1799794 (−4541G>A)
GG
100 (26.0)
108 (28.1)
1.00
0.838
0.271
GA
201 (52.4)
181 (47.1)
1.09 (0.78-1.53)
 
 
AA
83 (21.6)
95 (24.8)
0.86 (0.57-1.28)
 
 
XRCC3: rs1799796 (A17893G)
AA
178 (46.4)
171 (44.5)
1.00
0.231
0.406
AT
173 (45.0)
165 (43.0)
0.97 (0.72-1.31)
 
 
TT
33 (8.6)
48 (12.5)
0.64 (0.39-1.04)
 
 
BRCA2: rs1799943 (−26G>A)
GG
158 (41.2)
180 (46.9)
1.00
0.149
0.722
GA
186 (48.4)
168 (43.7)
1.22 (0.90-1.64)
 
 
AA
40 (10.4)
36 (9.4)
1.22 (0.74-2.01)
 
 
BRCA2: rs15869 (3' UTR)
AA
213 (55.5)
220 (57.3)
1.00
0.646
0.375
AC
143 (37.2)
137 (35.7)
1.05 (0.78-1.42)
 
 
CC
28 (7.3)
27 (7.0)
1.04 (0.59-1.83)
 
 
RAG1: rs2227973 (R820K)
GG
129 (33.6)
134 (34.9)
1.00
1.000
0.586
GA
200 (52.1)
190 (49.5)
0.96 (0.70-1.30)
 
 
AA
55 (14.3)
60 (15.6)
0.83 (0.54-1.29)
 
 
XRCC5: rs1051685 (3' UTR)
AA
313 (81.5)
326 (84.9)
1.00
0.232
0.808
AG
69 (18.0)
56 (14.6)
1.24 (0.84-1.82)
 
 
GG
2 (0.5)
2 (0.5)
1.00 (0.37-2.68)
 
 
LIG4: rs1805388 (T9I)
CC
163 (42.4)
222 (57.8)
1.00
< 0.001
0.659
CT
172 (44.8)
142 (37.0)
1.62 (1.20-2.18)
 
 
TT
49 (12.8)
20 (5.2)
3.27 (1.87-5.71)
 
 
XRCC4: rs1805377 (Splice Site)
AA
179 (46.6)
195 (50.8)
1.00
0.030
0.454
AG
143 (37.2)
153 (39.8)
0.96 (0.71-1.30)
 
 
GG
62 (16.2)
36 (9.4)
1.77 (1.12-2.80)
 
 
ATM: rs189037 (−111G/A)
GG
140 (36.5)
125 (32.5)
1.00
0.487
0.070
GA
186 (48.4)
203 (52.9)
0.78 (0.57-1.07)
 
 
AA 58 (15.1) 56 (14.6) 0.88 (0.57-1.37)    

aAdjusted for age, gender, smoking and drinking status.

bFalse Discovery Rate (FDR) corrected P-value.

P < 0.05 for bold significances.